HILLION Sophie



Enseignant-chercheur
Etablissement : Université Bretagne Occidentale
Affectation de recherche : (Immunologie et pathologie)

Equipe(s) : Immunothérapie du lymphocyte B
LogoUBO
Pour la messagerie : prénom.nom@univ-brest.fr
Page personnelle : Page perso

1-Hillion S, Saraux A, Youinou P, Jamin C. Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J  Immunology, 2005, 174, 5553.

2-Hillion S, Rochas C, Pennec YL, Devauchelle V, Youinou P, Jamin C. Expression and re-expression of recombination activation genes : relevance to the development of autoimmune states. Annals of the New York Academy of Sciences. 2005, 1050, 10.

3-Hillion S, Dueymes M, Youinou P, Jamin C. IL-6 contributes to the expression of RAGs in human mature B cells. J Immunology, 2007, 15, 23.


4-Hillion S, Garaud S, Devauchelle V, Berthou C, Youinou P, Jamin C. Interleukin-6 is responsible for aberrant BCR-mediated regulation of RAG expression in SLE. Immunology 2007, 122, 371.

5-Hillion S, Rochas C, Youinou P, Jamin C. Signaling pathways regulating RAG expression in B lymphocytes. J Autoimmun, 2009, 8, 599-604, IF: 7.8.

6-Hillion S, Seité JF, Gershwin ME, Berthou C, Shoenfeld Y, Youinou P. Hot from the battle front: IVIg renews the mechanisms of its B cell-specific effects. J Autoimmun, 2009.

7-Pallier A* , Hillion S* , Danger R , Giral M, Degauque N ,Racap M, Dugast E, Ashton-Chess J, Soulillou JP and Brouard S. Operationally tolerant kidney graft recipients display increased numbers of peripheral activated and memory Bcells with an inhibitory phenotype. Kidney Internnational, 2010, Sep;78(5):503-13 .(* co authors).

8-Seité JF, Cornec D, Youinou P, Mageed R, Hillion S. Intravenous immunoglobulins modulate BCR-signaling through CD22 and promote apoptosis of mature human B lymphocytes. Blood, 2010, Sep 9;116(10):1698-704.

9-Séité JF, Guerrier T, Cornec D, Jamin C, Youinou P, Hillion S. TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase. J Autoimmun. 2011 Nov;37(3):190-7,

10-Séïté JF, Goutsmedt C, Youinou P, Pers JO, Hillion S. Intravenous immunoglobulin induces afunctional silencing program similar to anergy in human B cells. J Allergy Clin Immunol. 2013 Oct 17.

11-Nouël A, Simon Q, Jamin C, Pers JO, Hillion S. Regulatory B cells: an exciting target for future therapeutics in transplantation. Front Immunol. 2014 Jan

12-Nouël A, Ségalen I, Jamin C, Doucet L, Caillard S, Renaudineau Y, Pers JO, Le Meur Y, Hillion S. B cells display an abnormal distribution and an impaired suppressive function in patients with chronicantibody-mediated rejection. Kidney Int. 2014 Mar;85(3):590-9.

13-Séïté JF, Hillion S, Harbonnier T, Pers JO. Intravenous immunoglobulin and B cells When the product regulates the producer. Arthritis Rheumatol. 2014 Oct 9.